Journal Finder

Best Practice & Research Clinical Endocrinology & Metabolism is a topical serial publication integrating the results from the latest original research into practical, evidence-based review articles that seek to address the key clinical issues of diagnosis, treatment and patient management.Each issue follows a problem-orientated approach which focuses on the key questions to be addressed, clearly defining what is known and highlighting topics for future research. Management is described in practical terms so that it can be applied to the individual patient. The series is aimed at the physician either in practice or in training.In practical paperback format, each 200 page issue of Best Practice & Research Clinical Endocrinology & Metabolism provides a comprehensive review of clinical practice and thinking within one specific area of endocrinology and metabolism.Each issue, written by an international team of contributors and guest edited by a renowned expert, form part of a continuous update of current clinical practice.• Attractive format and two-colour text layout• Six issues published annually• Highlighting the latest 'best practice' and 'clinical evidence'• Topic-based, problem-orientated approach• Recommendations on diagnosis, treatment and patient managementThe objective of the series is to provide the physician with the most up-to-date source of information in the field.

Best Practice & Research Clinical Haematology provides a comprehensive review of current clinical practice and thinking within the specialty of haematology.All chapters are commissioned and written by an international team of practising clinicians with the Guest Editors for each issue drawn from a pool of renowned experts and opinion leaders. Reference is made to:• The latest original research• Cochrane Reviews• Audits and confidential enquiries• National and international conferences• National and international guidelines• Personal communicationsAll chapters take the form of practical, evidence-based reviews that seek to address key clinical issues of diagnosis, treatment and patient management.Each issue follows a problem-orientated approach that focuses on the key questions to be addressed, clearly defining what is known and not known. Management will be described in practical terms so that it can be applied to the individual patient.Boxed and bulleted Learning Objectives and Practice Points are features within each chapter and will highlight the core and essential knowledge that will help the physician to provide the best care to their patients.The series' objective is to provide a continuous update for the busy clinician and researcher.

In practical paperback format, each 200 page topic-based issue of Best Practice & Research Clinical Obstetrics & Gynaecology will provide a comprehensive review of current clinical practice and thinking within the specialties of obstetrics and gynaecology.All chapters are commissioned and written by an international team of practising clinicians with the Guest Editors for each issue drawn from a pool of renowned experts and opinion leaders. Reference is made to:• The latest original research• Cochrane Reviews• Audits and confidential enquiries• National and international conferences• National and international guidelines• Personal communicationsAll chapters take the form of practical, evidence-based reviews that seek to address key clinical issues of diagnosis, treatment and patient management.Each issue follows a problem-orientated approach that focuses on the key questions to be addressed, clearly defining what is known and not known. Management will be described in practical terms so that it can be applied to the individual patient.Boxed and bulleted Learning Objectives and Practice Points are features within each chapter and will highlight the core and essential knowledge that will help the physician to provide the best care to their patients.The series' objective is to provide a continuous update for the busy clinician and researcher.2012 Topics: Volume 26 Issues 1-61. Haematological disorders in obstetrics and gynaecology, J. Hassan2. Screening for gynaecological cancers, L. Denny3. Microbicides in obstetrics and gynaecology, J. Moodley4. Fertility preservation in gynaecological cancer, A. Ilancheran and J. Low5. Advances in fetal genetic diagnosis and therapy, A. Biswas and M. Choolani6. Investigation and management of the infertile couple, P.C. Ho and E. Ng2013 Topics: Volume 27 Issues 1-61. Clinical aspects of sexual violence, M. Dalton2. Caesarean section - current practice, S. Arulkumaran3. Advances in gynaecological surgery, P. O'Donovan4. Risk management in obstetrics and gynaecology, L.C. Edozien5. Science of healthy aging, B. Lunenfeld and S. Arulkumaran6. Critical illness in obstetrics, A. Rhodes and N. Arulkumaran

Evidence-based updates of best clinical practice across the spectrum of musculoskeletal conditions.Best Practice & Research: Clinical Rheumatology keeps the clinician or trainee informed of the latest developments and current recommended practice in the rapidly advancing fields of musculoskeletal conditions and science.The series provides a continuous update of current clinical practice. It is a topical serial publication that covers the spectrum of musculoskeletal conditions in a 4-year cycle. Each topic-based issue contains around 200 pages of practical, evidence-based review articles, which integrate the results from the latest original research with current clinical practice and thinking to provide a continuous update.Each issue follows a problem-orientated approach that focuses on the key questions to be addressed, clearly defining what is known and not known. The review articles seek to address the clinical issues of diagnosis, treatment and patient management. Management is described in practical terms so that it can be applied to the individual patient. The serial is aimed at the physician in both practice and training.The Best Practice & Research Clinical Rheumatology series provides up-to-date and expert information and opinion by drawing on Guest Editors and authors renowned for their expertise. This ongoing review of topics makes the serial ideally suited to supporting everyday clinical practice, for training needs as well as for maintaining knowledge and competency.Volume 22 (Volume 2008):1. Connective tissue diseasesM. Matucci-Cerinic & D. Furst2. Musculoskeletal scienceT. Pap & U. Muller-Ladner3. How to manage chronic musculoskeletal conditions - the principlesP. Brooks & P. Conaghan4. Miscellanous inflammatory musculoskeletal conditionsJ. Sibilia & H. Zeidler5. Musculoskeletal conditions in the developing worldG. Mody & R. Handa6. Imaging in musculoskeletal conditionsM. Cimmino and W. GrassiVolume 23 (2009):1. Early rheumatoid arthritis2. Vasculitis3. How to do - practical procedures4. Back pain5. Systemic lupus erythematosus6. OsteoporosisVolume 24 (2010):1. Osteoarthritis2. Paediatric rheumatology3. How to manage chronic musculoskeletal conditions - a systematic approach to specific problems4. Pharmacotherapy5. Spondylo-arthropathies6. Prevention / epidemiologyThis free sample chapter is being provided to demonstrate the Journal's approach to topics across the spectrum of musculoskeletal conditions.

The journal aims to promote and communicate advances in big data research by providing a fast and high quality forum for researchers, practitioners and policy makers from the very many different communities working on, and with, this topic.The journal will accept papers on foundational aspects in dealing with big data, as well as papers on specific Platforms and Technologies used to deal with big data. To promote Data Science and interdisciplinary collaboration between fields, and to showcase the benefits of data driven research, papers demonstrating applications of big data in domains as diverse as Geoscience, Social Web, Finance, e-Commerce, Health Care, Environment and Climate, Physics and Astronomy, Chemistry, life sciences and drug discovery, digital libraries and scientific publications, security and government will also be considered. Occasionally the journal may publish whitepapers on policies, standards and best practices.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com.

BioSystems encourages experimental, computational, and theoretical articles that link biology, evolutionary thinking, and the information processing sciences. The link areas form a circle that encompasses the fundamental nature of biological information processing, computational modeling of complex biological systems, evolutionary models of computation, the application of biological principles to the design of novel computing systems, and the use of biomolecular materials to synthesize artificial systems that capture essential principles of natural biological information processing.The categories and topics listed below are examples, the editors will be happy to comment on the relevance of other topics:Molecular EvolutionSelf-organizing and self-replicating systemsOrigins and evolution of the genetic mechanismBiological Information ProcessingMolecular recognitionCellular controlNeuromolecular computingBiological adaptabilityMolecular computing technologiesEvolutionary SystemsStochastic evolutionary algorithmsEvolutionary optimizationSimulation of genetic and ecological systemsApplications (neural nets, machine learning, robotics)Please bookmark this page as: http://www.elsevier.com/locate/bioFor more information/suggestions/comments please contact AuthorSupport@elsevier.com

Bioactive Carbohydrates and Dietary Fibre is intended to be an international journal focused on dietary fibre, and bioactive carbohydrates (including bioactive polysaccharides, oligosaccharides and glycoproteins. It will include original studies and comprehensive reviews on the primary structure, molecular characteristics including conformation, size and shape, and bioactivities demonstrated by studies using in vitro, cell culture, animal and human clinical trials for understanding the action mechanisms and efficacy of bioactive carbohydrates from plants, fungi, animals and produced by biotechnology.Specific bioactivities such as reducing serum cholesterol, modulating blood glucose and insulin levels, fermentability in the gastrointestinal track, anti-tumor, anti-inflammatory, immune regulatory and anti-oxidant activities demonstrated by these bioactive carbohydrates are the main focus of this journal. It also covers the areas of interaction of dietary fibres, oligosaccharides, polysaccharides and glycoproteins with food matrices which may enhance or alter their efficacy, shelf-life stability of the bioactivities.Papers will cover such issues as:• Structural characterization of bioactive polysaccharides, oligosaccharides and glycoproteins• Conformation and molecular characteristics of bioactive polysaccharides, oligosaccharides and glycoproteins• Bioactivities of polysaccharides including: anti-cancer, immune modulation, anti-inflammatory, anti-oxidant etc• New anti-cancer polysaccharides from herbs• Recent advances in bioactive polysaccharides, oligosaccharides and glycoproteins• Analysis and physicochemical characterization of soluble and insoluble dietary fibre• Effects of dietary fibre on post-prandial blood glucose and/or insulin levels• Effect of dietary fibre on blood total and/or LDL cholesterol levels;• Effects of dietary fibre on gut function and ecology of microflora• Role of a diet rich in soluble fibre in reducing body weight• Development of dietary fibre industry• Animal and clinical trial studies• Updates on regulatory changes and legal constraints on nutritional dietary fibre and other food hydrocolloidsThe subject borders on medicine but is not a medical subject. The common factor for published papers is “bioactivity” and it's influence on health. Origin, husbanding, extraction, characterization, purification, cell culture, animal and clinical trials leading towards a medical or food supplemental applications will be considered. To be considered for this journal the research needs to cross-over from chemistry/biochemistry into biological investigation, with opportunities too for those who work on immune systems to contribute.Types of contribution:• Original research papers (full papers and short communications)• Invited reviews• Opinion pieces• Perspective commentaries.

Biocatalysis and Agricultural Biotechnology is the official journal of the International Society of Biocatalysis and Agricultural Biotechnology (ISBAB). The journal publishes high quality articles especially in the science and technology of biocatalysis, bioprocesses, agricultural biotechnology, biomedical biotechnology, and, if appropriate, from other related areas of biotechnology. The journal will publish peer-reviewed basic and applied research papers, authoritative reviews, and feature articles.The scope of the journal encompasses the research, industrial, and commercial aspects of biotechnology, including the areas of: biocatalysis; bioprocesses; food and agriculture; genetic engineering; molecular biology; healthcare and pharmaceuticals; biofuels; genomics; nanotechnology; environment and biodiversity; and bioremediation.Types of papers published are: Full-length original research papers; Short communications; Review articles; Letters to the Editor.

The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery, relevant to industries as diverse as medical/healthcare, food and environmental protection.Comments and Proposals: We are interested in receiving comments/feedback on this and our other journals and welcome publication proposals for books, electronic products, new journals and co-operation for existing journals.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Biochemical Pharmacology is devoted to publishing original work on the pharmacodynamics and pharmacokinetics of drugs and nontherapeutic xenobiotics. Its audience are scientists engaged in drug discovery and in identifying drug mechanisms of action. All areas of pharmacology are represented in the journal, including drug metabolism and kinetics. It is of particular value to those interested in anti-inflammatory drugs, cancer chemotherapy, neuropharmacology and cardiovascular pharmacology.While particular emphasis is placed on reporting findings that relate to the actions and metabolism of drugs and toxic substances at the biochemical and molecular levels, submissions in the areas of behavioral and physiological pharmacology and toxicology are also encouraged if they describe studies directed at defining mechanisms of action.Reports based on experiments conducted with mixtures, plant or animal extracts will not be considered for publication unless the chemical structures and concentrations of all substances are known and the compounds are obtained from commercial suppliers.The journal publishes the following types of reports:(1) Full-length Research Papers. These contain the results of original research on an issue of relevance to the field of pharmacology.(2) Commentaries. These are commissioned articles that provide the author's view on a selected topic of interest to pharmacologists.US National Institutes of Health (NIH) voluntary posting ("Public Access") policy Biochemical Pharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy.Please bookmark this URL: http://www.elsevier.com/locate/biochempharmBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Biochemical Systematics and Ecology is devoted to the publication of original papers and reviews, both submitted and invited, in two subject areas: (i) the application of biochemistry to problems relating to systematic biology of organisms (biochemical systematics); (ii) the role of biochemistry in interactions between organisms or between an organism and its environment (biochemical ecology). Papers will be grouped in each issue according to subject area. Research papers should generally be of completed investigations. Preliminary reports will be published where findings are considered to be of sufficient interest to justify rapid publication. In addition, short reports of new sources of known compounds (New Source Reports) will be accepted where they can be justified in terms of systematic or ecological significance. These reports must be written to a standard format.One volume will appear annually and eleven issues will constitute a volume. All manuscripts should be sent directly to the Editor-in-Chief, Professor Monique Simmonds. Before preparing their contributors, Authors are earnestly requested to study the latest Notes to Contributors, which were last published in Vol. 31, No. 5 (copies of these instructions are available from the Executive Editors.) The contents of papers are the sole responsibility of the Authors and publication does not imply the concurrence of Editors or Publisher.Biochemical Systematics and Ecology welcomes suitable books for review. Please send sample copies to the Editor-in-Chief.

BBRC -- the fastest submission-to-print journal!Number 1 journal in the Thomson's JCR ranking for Biophysics in terms of Total Cites, Number of Articles and Eigen Factor ™ score.From Submission to Online in Less Than 3 Weeks!Biochemical and Biophysical Research Communications is the premier international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. The development of the "Breakthroughs and Views" section brings the minireview format to the journal, and issues often contain collections of special interest manuscripts. BBRC is published weekly (52 issues/year).Research Areas now include:• Biochemistry• Bioinformatics• Biophysics• Cancer Research• Cell Biology• Developmental Biology• Immunology• Molecular Biology• Neurobiology• Plant Biology• ProteomicsBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Biochemistry and Biophysics Reports publishes original research in all aspects of Biochemistry, Biophysics and related areas like Molecular and Cell Biology. The primary criteria for acceptance are that the work is original, scientifically and technically sound and provides valuable knowledge to life sciences research.

Biochemistry and Biophysics Reports welcomes cutting-edge science and in-depth studies from authors seeking open access publishing. In addition, we welcome promising though more preliminary, descriptive and small scale results if they have potential to stimulate and/or contribute to future research. We also encourage research reports covering negative findings, as well as reanalyses of previous datasets and studies leading to new insights or hypothesis. We strongly believe all these results deserve to be published and documented for the advancement of science.

The journal offers a high-quality, impartial and constructive review process. Editors and Reviewers work with the Authors to ensure that accepted papers present sound results to be shared in a structured way with the life sciences community.

BBA Molecular Cell Research focuses on understanding the mechanisms of cellular processes at the molecular level. These include aspects of cellular signaling, signal transduction, cell cycle, apoptosis, intracellular trafficking, secretory and endocytic pathways, biogenesis of cell organelles, cytoskeletal structures, cellular interactions, cell/tissue differentiation and cellular enzymology. Also included are studies at the interface between Cell Biology and Biophysics which apply for example novel imaging methods for characterizing cellular processes.Reviews and mini-reviews on timely topics are considered for publication. Prospective authors of reviews should send a presubmission enquiry with key references tothe Editorial Office (email: bbareviews@elsevier.com). Color figures in reviews are published free of charge.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

BBA Reviews on Cancer covers the whole field of the biology and biochemistry of cancer, emphasizing oncogenes and tumor suppressor genes, growth-related cell cycle control signalling, carcinogenesis mechanisms, cell transformation, immunologic control mechanisms, genetics of human (mammalian) cancer, control of cell proliferation, genetic and molecular control of organismic development, rational anti-tumor drug design. In short, the journal presents critical invited reviews on new developments in cancer investigation at the molecular level.Types of papers published: mini-reviews, full reviews.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

BBA Molecular and Cell Biology of Lipids publishes papers on original research dealing with novel aspects of molecular genetics related to the lipidome, the biosynthesis of lipids, the role of lipids in cells and whole organisms, the regulation of lipid metabolism and function, and lipidomics in all organisms. Manuscripts should significantly advance the understanding of the molecular mechanisms underlying biological processes in which lipids are involved. Papers detailing novel methodology must report significant biochemical, molecular, or functional insight in the area of lipids.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Biochimie is a multi-topical journal, publishing original work as well as review articles and mini-reviews in all areas of biology (enzymology, genetics, immunology, microbiology, structure of macromolecules, etc.), provided that the approach adopted stems from biochemistry, biophysics or molecular biology.

Biochimie Open is a new online open access journal for author-financed manuscripts in all areas of biochemical, molecular and structural life sciences. Articles on Bioinformatics, Systems Biology, Toxicology, Molecular Pharmacology and Chemical Biology are also welcome. Sound scientific and technical quality is assured by peer review, and the acceptance of articles for publication is based on these qualities rather than editors' or referees' estimates of likely future impact.

Data that are exciting though more preliminary than those acceptable to many traditional journals will be considered for publication if the editors feel that they are likely to stimulate future research.

Biochimie Open offers authors the widest possible forum for their work, which is made freely available to all readers in all countries. Acceptance by Biochimie Open may help authors satisfy the requirements of funding agencies for open access publication. Accepted articles appear online within one week, and authors retain copyright over their published work.

Biochimie Open welcomes direct submission from authors seeking open access publishing. In addition, articles first submitted to Biochimie, the traditional subscription journal of the SFBBM may, if appropriate and with the agreement of the authors, be transferred for consideration by Biochimie Open, without the need for resubmission.